Catheterization Lab Equipment in North Carolina

Teleflex Incorporated is a NYSE-listed (TFX) global medical technology company headquartered in Morrisville, North Carolina. The company designs, manufactures, and distributes innovative medical devices and solutions across multiple clinical specialties including anesthesia, emergency medicine, interventional cardiology and radiology, interventional urology, surgical care, general urology, and vascular access. Teleflex serves healthcare professionals and patients through a diversified portfolio of critical care and procedural products. The company recently completed the acquisition of BIOTRONIK's Vascular Intervention Business, expanding its interventional capabilities. Key product areas include anesthesia delivery systems, emergency airway and resuscitation equipment, catheterization laboratory instrumentation, urological devices (including the UroLift system), surgical instruments and staplers (such as the Titan SGS stapler for bariatric surgery), and vascular access devices. Teleflex also serves military and federal healthcare markets. The company operates Teleflex Academy, a comprehensive education platform providing training and professional development for healthcare organizations and clinicians. Teleflex maintains significant research and development capabilities with multiple design centers, supporting ongoing innovation in medical device technology. The company is recognized as a Forbes Best Employer for Engineers (2025) and received the VETS Indexes Recognized Employer Award for the second consecutive year, reflecting its commitment to recruiting and supporting veterans. Manufacturing and service capabilities span multiple geographic locations, with strong regulatory and quality management systems supporting FDA, ISO, and international compliance requirements.

ABK Biomedical is a clinical-stage medical device company specializing in radioembolization and embolization technologies for cancer treatment, particularly hepatocellular carcinoma and hypervascular tumors. The company develops and commercializes proprietary imageable microsphere products designed for interventional radiology procedures. Key product lines include Eye90 microspheres, a novel yttrium-90 radioembolization technology with proprietary glass composition enabling in-procedure visualization for unresectable liver cancer, and Easi-Vue embolic microspheres, an imageable bland embolization product cleared by FDA 510(k) for treating arteriovenous malformations and hypervascular tumors. ABK Biomedical is currently conducting the Route90 pivotal clinical study evaluating Eye90 in unresectable hepatocellular cancer; enrollment was recently completed. The company holds ISO 13485 certification for medical device quality management and maintains partnerships with leading academic institutions and research organizations including Dalhousie University, NC State University, MD Anderson Cancer Center, Northwestern University, and the University of Missouri Research Reactor (MURR). Manufacturing partnerships include agreements with COR Development and Paragon Medical. The company operates as a research and development organization with headquarters in Halifax, Nova Scotia, Canada, and a development office in Orange County, California. Eye90 microspheres remain investigational and are not FDA-approved for commercial use.

Hydromer, Inc. is a global B2B provider of surface modification and coating solutions, specializing in hydrophilic polymer research, development, and manufacturing. Founded in 1980 and based in Concord, North Carolina, the company is ISO 9001:2015 certified with over 40 years of expertise in creating innovative polymer-based products for medical devices, industrial plastics, and specialized applications. Hydromer offers a comprehensive portfolio of hydrophilic coatings—including UV-curable and thermal-curable systems—tailored for cardiovascular, gastroenterology, neurovascular, ophthalmology, peripheral vascular, and urological devices. The company provides end-to-end services including custom formulation development, contract coating, R&D services, FDA regulatory support, and technology transfer. With a 98% repeat customer rate and support for over 1,000 medical device customers worldwide, Hydromer delivers lubricious, anti-thrombogenic, and performance-enhanced coatings for catheters, guidewires, balloons, stents, endoscopes, and other interventional and diagnostic devices. Global production and service hubs ensure consistent quality and responsive support across Asia and the Americas.